Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Isabella Ramos Lima"'
Autor:
Isabella Ramos Lima, Mauricio Teruo Tada, Theo G.M. Oliveira, Cinthia Elim Jannes, Isabela Bensenor, Paulo A. Lotufo, Raul D. Santos, Jose E. Krieger, Alexandre C. Pereira
Publikováno v:
Atherosclerosis Plus, Vol 49, Iss , Pp 47-55 (2022)
Background and aims: Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of LDL-C leading to premature cardiovascular disease (CAD). Only about 40% of individuals with a clinical diagnosis of FH have a causative gene
Externí odkaz:
https://doaj.org/article/91bd4a9f5d294aae81f1d9573bdd8f2f
Autor:
Cinthia Elim Jannes, Júnea Paolucci Paiva Silvino, Pãmela Rodrigues de Souza Silva, Isabella Ramos Lima, Mauricio Teruo Tada, Theo Gremen Mimary Oliveira, Raul D. Santos, José Eduardo Krieger, Alexandre da Costa Pereira
Publikováno v:
Arquivos Brasileiros de Cardiologia (2022)
Resumo Fundamento A hipercolesterolemia familiar (HF) é uma doença genética dominante que se caracteriza por níveis sanguíneos elevados de colesterol de lipoproteína de baixa densidade (LDL-C), e está associada à ocorrência de doença cardio
Externí odkaz:
https://doaj.org/article/c5e03c2829484bf785ba733811c95a26
Autor:
Isabela Bensenor, Kallyandra Padilha, Isabella Ramos Lima, Raul Dias Santos, Gilles Lambert, Stéphane Ramin-Mangata, Marcio S Bittencourt, Alessandra C Goulart, Itamar S. Santos, Jose G Mill, Jose E Krieger, Paulo A. Lotufo, Alexandre C. Pereira
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Pharmacological inhibition of PCSK9 (proprotein convertase subtilisin/kexin type 9) is an established therapeutic option to treat hypercholesterolemia, and plasma PCSK9 levels have been implicated in cardiovascular disease incidence. A number of gene
Externí odkaz:
https://doaj.org/article/40ce06bc30634a589f2163df9294e2a7
Autor:
Isabella Ramos Lima
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
A hipercolesterolemia familiar (HF) é uma doença genética autossômica dominante, caracterizada por níveis elevados de colesterol de baixa densidade (LDL-C) e consequente aumento do risco de doenças cardiovasculares (DCV) prematuras, como aciden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ad626f5423a81b8697ff11781b0fdb
Autor:
José Eduardo Krieger, Mauricio Teruo Tada, Alexandre C. Pereira, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, Luiza Antoniazzi, Márcio Sommer Bittencourt, Pedro Mata, José Luis Díaz-Díaz, Cinthia E. Jannes, Isabella Ramos Lima, Gracia M. Quintana-Navarro, Rodrigo Alonso, Raul D. Santos
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 31:2014-2022
Familial Hypercholesterolemia (FH) is characterized by elevated LDL-cholesterol (LDL-C) and high atherosclerosis risk. The impact of different dietary patterns on atherosclerosis biomarkers has been poorly studied in FH. This study verified the assoc
Autor:
Mauricio Teruo Tada, Viviane Zorzanelli Rocha, Isabella Ramos Lima, Théo Gremen Mimary Oliveira, Ana Paula Chacra, Marcio Hiroshi Miname, Valéria Sutti Nunes, Edna Regina Nakandakare, Maria Helane Costa Gurgel Castelo, Cinthia Elim Jannes, Raul D. Santos, José Eduardo Krieger, Alexandre Costa Pereira
Publikováno v:
Circulation: Genomic and Precision Medicine. 15
Background: Sitosterolemia is a rare autosomal recessive disorder caused by homozygous or compound heterozygous variants in ABCG5/ABCG8 . The disease is characterized by increased plasma plant sterols. Small case series suggest that patients with sit
Autor:
Mauricio Teruo, Tada, Viviane Zorzanelli, Rocha, Isabella Ramos, Lima, Théo Gremen Mimary, Oliveira, Ana Paula, Chacra, Marcio Hiroshi, Miname, Valéria Sutti, Nunes, Edna Regina, Nakandakare, Maria Helane, Costa Gurgel Castelo, Cinthia Elim, Jannes, Raul D, Santos, José Eduardo, Krieger, Alexandre Costa, Pereira
Publikováno v:
Circulation. Genomic and precision medicine. 15(3)
Sitosterolemia is a rare autosomal recessive disorder caused by homozygous or compound heterozygous variants inFrom 443 familial hypercholesterolemia index cases, 260 were negative for familial hypercholesterolemia genes and were sequenced for theEig
Autor:
Karina Braga Gomes, Mauricio Teruo Tada, Júnea Paolucci de Paiva Silvino, Alexandre C. Pereira, Cinthia E. Jannes, Isabella Ramos Lima, Ieda de Fátima Oliveira Silva
Publikováno v:
Molecular Biology Reports. 47:9279-9288
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease characterized by high levels of low-density lipoprotein-cholesterol (LDLc), associated to premature cardiovascular disease. The detection of the variants related to FH is imp
Autor:
Mauricio Teruo Tada, Pãmela Rodrigues de Souza Silva, Alexandre Costa Pereira, Isabella Ramos Lima, Theo G M Oliveira, Raul D. Santos, José Eduardo Krieger, Cinthia E. Jannes, Júnea Paolucci de Paiva Silvino
Publikováno v:
Arquivos Brasileiros de Cardiologia n.ahead 2022
Arquivos Brasileiros de Cardiologia
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia, Volume: 118, Issue: 4, Pages: 669-677, Published: 07 FEB 2022
Arquivos Brasileiros de Cardiologia (2022)
Arquivos Brasileiros de Cardiologia v.118 n.4 2022
Arquivos Brasileiros de Cardiologia
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia, Volume: 118, Issue: 4, Pages: 669-677, Published: 07 FEB 2022
Arquivos Brasileiros de Cardiologia (2022)
Arquivos Brasileiros de Cardiologia v.118 n.4 2022
Resumo Fundamento A hipercolesterolemia familiar (HF) é uma doença genética dominante que se caracteriza por níveis sanguíneos elevados de colesterol de lipoproteína de baixa densidade (LDL-C), e está associada à ocorrência de doença cardio
Autor:
Kallyandra Padilha, Itamar S. Santos, Isabella Ramos Lima, José Geraldo Mill, Isabela M. Benseñor, Stéphane Ramin-Mangata, José Eduardo Krieger, Paulo A. Lotufo, Raul D. Santos, Alexandre C. Pereira, Gilles Lambert, Márcio Sommer Bittencourt, Alessandra C. Goulart
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Frontiers in Genetics
Frontiers in Genetics
Pharmacological inhibition of PCSK9 (proprotein convertase subtilisin/kexin type 9) is an established therapeutic option to treat hypercholesterolemia, and plasma PCSK9 levels have been implicated in cardiovascular disease incidence. A number of gene